pubmed-article:3002375 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:3002375 | lifeskim:mentions | umls-concept:C0008354 | lld:lifeskim |
pubmed-article:3002375 | lifeskim:mentions | umls-concept:C0001455 | lld:lifeskim |
pubmed-article:3002375 | lifeskim:mentions | umls-concept:C0021467 | lld:lifeskim |
pubmed-article:3002375 | lifeskim:mentions | umls-concept:C1280500 | lld:lifeskim |
pubmed-article:3002375 | lifeskim:mentions | umls-concept:C0041370 | lld:lifeskim |
pubmed-article:3002375 | lifeskim:mentions | umls-concept:C0443199 | lld:lifeskim |
pubmed-article:3002375 | lifeskim:mentions | umls-concept:C1948023 | lld:lifeskim |
pubmed-article:3002375 | lifeskim:mentions | umls-concept:C0021469 | lld:lifeskim |
pubmed-article:3002375 | lifeskim:mentions | umls-concept:C0279023 | lld:lifeskim |
pubmed-article:3002375 | lifeskim:mentions | umls-concept:C0033268 | lld:lifeskim |
pubmed-article:3002375 | pubmed:issue | 3 | lld:pubmed |
pubmed-article:3002375 | pubmed:dateCreated | 1986-2-12 | lld:pubmed |
pubmed-article:3002375 | pubmed:abstractText | Tetradecanoylphorbol-acetate and other tumor promoters inhibit prostaglandin E2 and isoproterenol-induced cAMP accumulation in mouse thymocytes but markedly potentiate cAMP production induced by cholera toxin. Cholera toxin is known to stimulate cAMP production by inducing ADP-ribosylation of the alpha-subunit of a guanine nucleotide-binding regulatory (G) protein, resulting in activation of the catalytic unit of adenylate cyclase. G proteins have been implicated as plasma membrane transducers for a variety of additional signals. It is possible that the growth promoting and co-mitogenic properties of tumor promoters are related to their effects on G proteins. | lld:pubmed |
pubmed-article:3002375 | pubmed:language | eng | lld:pubmed |
pubmed-article:3002375 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:3002375 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:3002375 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:3002375 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:3002375 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:3002375 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:3002375 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:3002375 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:3002375 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:3002375 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:3002375 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:3002375 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:3002375 | pubmed:month | Dec | lld:pubmed |
pubmed-article:3002375 | pubmed:issn | 0006-291X | lld:pubmed |
pubmed-article:3002375 | pubmed:author | pubmed-author:NovogrodskyAA | lld:pubmed |
pubmed-article:3002375 | pubmed:author | pubmed-author:StenzelK HKH | lld:pubmed |
pubmed-article:3002375 | pubmed:author | pubmed-author:PatykSS | lld:pubmed |
pubmed-article:3002375 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:3002375 | pubmed:day | 31 | lld:pubmed |
pubmed-article:3002375 | pubmed:volume | 133 | lld:pubmed |
pubmed-article:3002375 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:3002375 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:3002375 | pubmed:pagination | 904-10 | lld:pubmed |
pubmed-article:3002375 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
pubmed-article:3002375 | pubmed:meshHeading | pubmed-meshheading:3002375-... | lld:pubmed |
pubmed-article:3002375 | pubmed:meshHeading | pubmed-meshheading:3002375-... | lld:pubmed |
pubmed-article:3002375 | pubmed:meshHeading | pubmed-meshheading:3002375-... | lld:pubmed |
pubmed-article:3002375 | pubmed:meshHeading | pubmed-meshheading:3002375-... | lld:pubmed |
pubmed-article:3002375 | pubmed:meshHeading | pubmed-meshheading:3002375-... | lld:pubmed |
pubmed-article:3002375 | pubmed:meshHeading | pubmed-meshheading:3002375-... | lld:pubmed |
pubmed-article:3002375 | pubmed:meshHeading | pubmed-meshheading:3002375-... | lld:pubmed |
pubmed-article:3002375 | pubmed:meshHeading | pubmed-meshheading:3002375-... | lld:pubmed |
pubmed-article:3002375 | pubmed:meshHeading | pubmed-meshheading:3002375-... | lld:pubmed |
pubmed-article:3002375 | pubmed:meshHeading | pubmed-meshheading:3002375-... | lld:pubmed |
pubmed-article:3002375 | pubmed:meshHeading | pubmed-meshheading:3002375-... | lld:pubmed |
pubmed-article:3002375 | pubmed:meshHeading | pubmed-meshheading:3002375-... | lld:pubmed |
pubmed-article:3002375 | pubmed:meshHeading | pubmed-meshheading:3002375-... | lld:pubmed |
pubmed-article:3002375 | pubmed:meshHeading | pubmed-meshheading:3002375-... | lld:pubmed |
pubmed-article:3002375 | pubmed:year | 1985 | lld:pubmed |
pubmed-article:3002375 | pubmed:articleTitle | Differential effects of tumor promoters on cAMP production: inhibition of receptor-mediated and potentiation of cholera toxin-mediated stimulation. | lld:pubmed |
pubmed-article:3002375 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:3002375 | pubmed:publicationType | Comparative Study | lld:pubmed |
pubmed-article:3002375 | pubmed:publicationType | In Vitro | lld:pubmed |